Codeine Regulation Change To Further Impact Australian Market?

 In Australia, Pharmacy

New regulations restricting the sale of codeine to a prescription only medication has left retailers and manufacturers with a keen interest in the future trends in analgesics. In 2017 codeine was worth $170 million dollars, making up 20% of the analgesics industry. Understanding where this value may move to is key for the pharmaceutical industry in the coming year and beyond.
However, Nielsen research findings show that codeine sales have been in decline for the last three years before the regulation went into effect. Nielsen and IQVIA Scantrack data from 2015 to year-end 2017 show the sales decreasing at -8.7% and -10.4% respectively. This decline could be attributed to pharmacies putting less codeine based products on the shelf, and the 8% rise in the price of codeine over the last few years making it expensive for consumers to purchase. Nielsen – Read more…

Recent Posts

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.